Skip to content

Venous Obstruction in Neurodegenerative Disorders Research Registry

Venous Obstruction in Neurodegenerative Disorders Research Registry

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01593358
Enrollment
2000
Registered
2012-05-08
Start date
2011-08-31
Completion date
2014-01-31
Last updated
2012-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Cerebral Spinal Venous Insufficiency

Keywords

CCSVI

Brief summary

To establish if there are venous obstructions in patients with neurodegenerative disorders

Detailed description

This research registry will observe the venous obstruction in neurodegenerative disorders. This will provide data that will allow researchers to classify abnormal valve and venous morphology, distinguish vessels which are more responsive to treatment, determine groups who respond more favorably to treatment, and overall evaluate the outcomes of venous angioplasty in various neurodegenerative disorders that involve venous obstruction.

Interventions

None listed

Sponsors

Synergy Health Concepts, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Ability to comprehend the nature of the study, including the risks and benefits and execute an informed consent * Males or Females between the ages of 18 and 90 years of age * Voluntary agreement to participate in the Venous Obstructions in Neurodegenerative Diseases Research Registry

Exclusion criteria

* Any implantable/metallic objects that prevent subject from having a magnetic resonance imaging ( MRI/MRV) study * History of uncontrolled hypertension * Previous venous angioplasty treatment for Chronic cerebral spinal venous insufficiency * Special Populations. Special groups include, but are not limited to children, prisoners, pregnant women,fetuses, and cognitively impaired individuals who are unable to provide informed consent

Countries

United States

Contacts

Primary ContactFrances DeBarge-Igoe, RN
uscangionurse@aol.com(949) 221-0129

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026